TY - JOUR
T1 - Rabies post-exposure prophylaxis
T2 - A retrospective analysis of timing of initiation and antibody responses in a Belgian cohort
AU - Hens, Matilde
AU - Declercq, Steven
AU - Berens-Riha, Nicole
AU - Maniewski, Ula
AU - Theunissen, Caroline
AU - Van Den Broucke, Steven
AU - De Bièvre, Felix
AU - Brosius, Isabel
AU - Liesenborghs, Laurens
AU - Van Dijck, Christophe
AU - Burm, Christophe
AU - Nauwelaers, Inne
AU - Balliauw, Katleen
AU - Visser, Benjamin J.
AU - Bottieau, Emmanuel
AU - Soentjens, Patrick
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2024/11/1
Y1 - 2024/11/1
N2 - Background: We aimed to determine the timeliness of rabies post-exposure prophylaxis (PEP) and the proportion of individuals with an adequate antibody response post-PEP among those attending the Belgian national reference center. Methods: Retrospective analysis of patient records who attended our center from 2018 to 2023. Delay was defined as rabies immunoglobulin (RIG) and vaccine initiation beyond 2 calendar days after exposure. Antibodies were measured by rapid fluorescent focus inhibition test (RFFIT) after PEP in high-risk exposures. A titer ≥0.5 IU/ml was considered adequate. Results: We reviewed 317 patient records. Among individuals with inland exposure (n = 103), 85 % timely received PEP. Among travelers exposed abroad (n = 214), administration of RIG and vaccine initiation were timely in 30 % and 50 % of cases, respectively. An adequate antibody response was detected in 99.5 % (195/196) individuals. Conclusion: Substantial PEP delays among travelers were observed. The robust antibody responses suggest that routine serological follow-up is not necessary for all patients.
AB - Background: We aimed to determine the timeliness of rabies post-exposure prophylaxis (PEP) and the proportion of individuals with an adequate antibody response post-PEP among those attending the Belgian national reference center. Methods: Retrospective analysis of patient records who attended our center from 2018 to 2023. Delay was defined as rabies immunoglobulin (RIG) and vaccine initiation beyond 2 calendar days after exposure. Antibodies were measured by rapid fluorescent focus inhibition test (RFFIT) after PEP in high-risk exposures. A titer ≥0.5 IU/ml was considered adequate. Results: We reviewed 317 patient records. Among individuals with inland exposure (n = 103), 85 % timely received PEP. Among travelers exposed abroad (n = 214), administration of RIG and vaccine initiation were timely in 30 % and 50 % of cases, respectively. An adequate antibody response was detected in 99.5 % (195/196) individuals. Conclusion: Substantial PEP delays among travelers were observed. The robust antibody responses suggest that routine serological follow-up is not necessary for all patients.
KW - Delay
KW - PEP
KW - Rabies
KW - Rabies immunoglobulins
KW - Rabies vaccination
KW - Rabies virus neutralizing antibodies
UR - https://www.scopus.com/pages/publications/85204366900
U2 - 10.1016/j.tmaid.2024.102761
DO - 10.1016/j.tmaid.2024.102761
M3 - Article
C2 - 39306187
AN - SCOPUS:85204366900
SN - 1477-8939
VL - 62
JO - Travel Medicine and Infectious Disease
JF - Travel Medicine and Infectious Disease
M1 - 102761
ER -